The epidemiological distribution of KRAS G12C mutations varies significantly across different tumor types, reflecting the complex interplay between genetic susceptibility, environmental exposures, and tissue-specific oncogenic pathways [4]. The gene discussed is KRAS; the disease is neoplasm.